查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1830486

脐带血银行市场（按银行模式、产品、应用和最终用户划分）—2025-2032 年全球预测

Umbilical Cord Blood Banking Market by Banking Model, Offerings, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年脐带血库市场规模将成长 1,184.4 亿美元，复合年增长率为 17.28%。

主要市场统计数据
基准年2024年 330.8亿美元
预计2025年 389.2亿美元
预测年份：2032年 1184.4亿美元
复合年增长率（%） 17.28%

全面说明脐带血库的不断发展，重点在于影响策略决策的临床前景、营运要求和监管环境

脐带血库领域正处于临床前景、技术创新和不断变化的监管预期的十字路口。细胞处理和冷冻保存技术的进步重新激发了临床医生、研究人员和准父母的兴趣，而不断扩展的治疗应用也促使行业和监管机构之间进行更深入的对话。因此，相关人员目前正在探索一个将长期生物资产储存与短期转化科学结合的格局。

实际上，银行模式和服务产品反映了不同的价值提案。私人银行专注于自体移植并单独储存以供家庭使用，而公共银行则专注于用于移植和研究的异体移植。同时，实验室自动化、品管和生存评估的改进降低了操作差异性，并提高了不同供应商之间的一致性。法律规范继续塑造可接受的活动和商业化路径，而将临床证据生成与强大的品质系统相结合的组织正在获得差异化的信誉。

本引言概述了以下核心动态：生态系统范围内的结构性转变、贸易行动带来的政策压力、特定领域的驱动因素，以及为那些必须将科学机会转化为可信赖、合规动态的领导者提供的实用建议。本书的其余部分将以此为视角，概述中短期内对策略选择影响最大的力量。

科学进步、营运标准化和不断发展的临床伙伴关係如何重塑整个产业的竞争重点和品质期望

在科学进步、处理技术改进以及相关人员期望转变的推动下，脐带血库格局正在发生重大变化。再生医学和细胞疗法的突破正在拓展脐带血储存的临床应用，促使现有脐带血库和新进者重新思考其服务模式并重视沟通。同时，自动化和标准化的活力测试正在提高看护者和研究人员目前期望的基线质量，将竞争从价格转向临床效用的展示。

此外，银行机构与生技公司之间的伙伴关係正在加速转化途径。此类合作促进了对支持免疫疗法和再生医学等新型应用通讯协定的共同投资。同时，付款人和医疗保健系统开始评估长期疗效，这将影响报销情况和患者需求。监管机构也在调整其监管框架，以适应新兴细胞疗法，并制定新的合规要求，这需要製定积极主动的品质和文件策略。

综合来看，这些因素正在重塑整个产业的战略重点。那些投资于证据生成、加强可追溯性和低温运输管治、并建立临床伙伴关係关係的组织将更有能力应对这项转型。

评估2025年贸易政策调整和关税如何改变该产业的采购、供应链弹性和合作研究策略

美国2025年贸易政策措施和关税调整的实施，为活跃于支持脐带血库的全球供应链中的组织带来了一系列新的营运和策略压力。专用超低温冷冻库、实验室耗材和试剂的采购通常依赖跨境供应商，而关税导致的投入成本增加，使得筹资策略必须立即重新评估。这促使许多相关人员加速供应商多元化，并加强了关于近岸外包关键製造产能的讨论。

除了采购之外，关税也影响了合作研究安排。跨国临床合作和试剂共用需要明确的合约条款来管理成本波动。研究机构已采取措施，修改合约风险分配，并为时间敏感型试剂建立库存缓衝。此外，成本透明度的提高也促进了资源利用的创新，包括优化储存安排和改进减量技术，以减少每个检体的耗材消费量。

从策略角度来看，关税环境促使人们更加重视供应链的透明度和韧性。先前在供应商资格确认和紧急时应对计画方面投入不足的组织已经重新评估了这些优先事项。相反，那些利用战略采购、长期供应商协议以及对国内产能进行增量投资的组织，最大限度地减少了中断，并保持了临床和研究活动的连续性。

深度細項分析揭示了银行模式、服务产品、临床应用和最终用户期望的明确需求，这些需求推动了策略差异化

从银行模式的角度评估市场，我们发现专注于个人託管服务的供应商与专注于公共服务及移植支援的供应商之间存在着明显的差异。私人银行倾向于投资与消费者教育、长期客户维繫和家庭服务相关的价值提案，而公共银行则优先考虑捐赠者招募、配对系统以及与国家移植网路的整合。

即确保出生时无菌且及时恢復的采集流程，包括细胞分离、活力检测和用于冷冻保存的减容处理能力，用于移植或研究的临床调度放行程序，以及在严格的可追溯性和温度控制下保持样本完整性的长期储存系统。这些阶段的创新可能会对下游效用和成本结构产生重大影响。

基于应用的细分突出了临床和科研重点。贫血、白血病和淋巴瘤等血液疾病仍然是脐带血移植的核心治疗目标，而免疫和代谢疾病仍是研究的重点。再生医学和研究应用拓展了储存脐带血的潜在效用，但需要进一步的疗效和长期疗效数据来支持其更广泛的应用。

最后，诊断实验室、医院、诊所和研究机构等终端使用者与资料库的合作时间表和品质期望各不相同。另一方面，医院和诊所要求在数据采集和无缝临床整合方面实现卓越的营运。研究机构则优先考虑可访问性和标准化元资料，以实现可重复的研究。了解这些细分市场中细微的需求，有助于制定个人化的服务设计和合约结构。

美洲、中东和非洲以及亚太地区的区域动态和监管细微差别决定了投资重点和战略伙伴关係

区域动态对法律规范、付款人态度以及脐带血库生态系统的成熟度有着强大的影响。在美洲，成熟的私人银行网路与公共登记机构并存，临床中心拥有丰富的移植经验，支持高品质脐带血库的持续需求。区域监管机构正在逐步更新其指导方针，以适应细胞疗法，营利性公司通常强调消费者参与度和产品差异化。

监管协调工作和国家组织授权塑造了欧洲、中东和非洲地区的营运要求。公共银行基础设施和国家登记系统在某些国家发挥关键作用，而跨国合作则支持移植配对。不同国家和地区的监管差异要求银行投资跨境合规计画和本地临床伙伴关係关係，以确保服务多样化的病患群体。

在亚太地区，新型治疗方法的快速应用以及对生物技术基础设施的投资正在推动对私人和公共银行业务的需求。临床试验和转化研究的发展为银行与药物开发商之间的合作模式创造了机会。然而，由于监管成熟度和报销环境的差异，区域策略需要兼顾文化、临床和政策差异。这些区域差异将决定基础设施、临床推广和合规能力的投资重点。

竞争格局评估：展示联盟、技术差异化和整合如何重新定义公司的策略和价值创造路径

脐带血库产业的竞争态势体现了传统脐血库、垂直整合的临床服务机构以及致力于商业化新型处理和分析技术的敏捷新兴企业的混合。现有脐血库通常利用其采集网路、客户关係和规模优势进行长期储存运营，而新进业者则通常专注于差异化的检测能力、专有的可行性检测法或与疗法开发商的合作。

随着研发人员为其临床计画寻求可靠、高品质的原料，生物库与生技公司之间的策略联盟正变得越来越普遍。这些联盟通常包括对处理方案、验证研究和资料共用协议的联合投资，以加快转换进度。同样，提供自动化处理平台和先进低温处理硬体的技术供应商也为生物库创造了提高品质标准和降低单位差异的机会。

併购持续影响竞争格局，整合不仅能够在储存和合规方面实现规模经济，还能推动临床和研究服务的整合。同时，机构投资者和医疗保健系统正在探索合资专属式和专属银行解决方案，以确保其内部治疗产品线能够获得合格的捐赠者材料。总而言之，这些企业级策略反映出一个市场，在这个市场中，差异化越来越依赖证据产生、供应链可靠性以及支持临床开发合作伙伴的能力。

领导者可操作的策略重点是临床证据产生、营运弹性、策略伙伴关係和客户参与，以确保长期价值

产业领导者应优先考虑平衡的方法，在增强临床可信度的同时建立营运韧性。首先，透过前瞻性註册和临床医生伙伴关係，投资于证据生成，以证明在目标适应症中的临床效用。同时，将这些努力与强大的品质系统和透明的文件相结合，以促进与监管机构的互动，并支持与付款方的对话。

第二，透过多元化关键设备和耗材供应商、尽可能签订多年合约以及探索区域製造地和采购地点来增强供应链弹性，以缓解关税相关的波动。同时，采用实验室自动化和标准化可行性测试，以减少操作差异，并提高转换专案中的单元效用。

第三，与治疗开发公司和研究机构建立策略联盟。共同开发契约和材料获取安排可以创造新的收益来源，并加速脐带血衍生应用的临床检验。最后，透过数位入口网站增强面向客户的能力，从而实现更清晰的教育、储存后的互动、简化的长期储存决策以及生命週期收益机会。结合这些行动，将使组织能够抓住临床机会，同时管理监管和商业风险。

一个强大的混合方法研究框架，结合专家访谈、监管机构审查和数据三角测量来支持基于证据的策略建议

本研究整合了主要相关人员访谈、监管和临床文献综述以及对工作实践的观察性分析，以得出基于证据的结论。主要相关人员访谈包括与实验室主任、移植临床医生、采购专业人员和监管专家进行结构化对话，以了解现实世界的挑战和不断变化的期望。此外，我们也仔细查阅了指导文件、临床试验註册中心以及记录操作创新和治疗结果的同行评审研究，以补充这些访谈。

二次研究整合了行业出版物、技术供应商规范和公开的政策更新，以便将营运趋势置于更广泛的贸易和监管格局中。资料三角检验确保了不同资讯来源的一致性，并将差异性结果与后续研究或其他资料管道进行交叉检验。品质保证流程包括专家同侪审查和情境分析，以确定对政策变化和技术采用曲线的合理应对措施。

调查方法着重于定性深度而非推测性的定量预测，使读者能够理解将科学可能性转化为可靠服务所需的因果关係、操作手段和实际步骤。为了支持自信的决策，我们对所有关键声明（包括来源归属和调查方法限制）保持透明。

结论：品质、策略伙伴关係和供应链弹性将决定哪些组织引领下一阶段的治疗和临床应用

科学进步、运作标准化和地缘政治压力的交汇，正在深刻重塑脐带血库生态系统。如今，临床机会与对可追溯性、品质和协作证据生成日益增长的期望并存。同时，供应链中断和关税趋势凸显了采购敏捷性和本地能力建构的重要性。

将实验室卓越性与积极主动的监管参与和策略伙伴关係相结合的组织将获得竞争优势。对经过验证的处理通讯协定、自动化可行性测试和持续的临床关係的投资，为长期的相关性奠定了基础。相反，那些在整合新技术方面进展缓慢或未能增强供应链韧性的公司，则可能面临营运中断和临床可靠性下降的风险。

最后，那些将脐带血库不仅仅视为一项储存服务，更视为转化科学重要合作伙伴的营运商将在该产业的发展轨迹中受到青睐。透过强调品质、协作和适应性，领导者可以在保护储存生物资产完整性的同时，开拓更广泛的临床应用。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 越来越多地采用先进的冷冻保存技术来提高储存脐带血干细胞的活力和寿命
  • 推动人工智慧与区块链的整合，提高脐带血储存和使用的可追溯性和透明度
  • 个人化医疗的出现推动了针对性免疫治疗的 HLA 型脐带血单位的需求
  • 扩大公私混合脐带血库，改善新兴国家的可及性
  • 增加脐带血造血干细胞体外扩增研究的投入，以扩大其临床应用范围
  • 协调监管工作，制定脐带血库服务品质和安全的国际标准
  • 生技公司和脐带血库合作利用新生儿干细胞商业化新型细胞治疗产品
  • 以消费者为中心的行销宣传活动，强调自体脐带血库的未来治疗潜力
  • 采用微创采集套件，方便孕妇在家采集脐带血
  • 推出经济高效的模组化储存解决方案，以降低脐带血库的营运费用

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. 脐带血银行市场（依银行模式）

  • 私人的
  • 公共

9. 脐带血库市场（依产品类型）

  • 收藏
  • 流程
    • 细胞分离
    • 活力测试
    • 体积缩减
  • 发布
  • 贮存

第 10 章脐带血库市场（依应用）

  • 血液疾病
    • 贫血
    • 白血病
    • 淋巴瘤
  • 免疫疾病
  • 代谢紊乱
  • 再生医学
  • 调查

第 11 章脐带血库市场（依最终用户划分）

  • 诊断实验室
  • 医院和诊所
  • 研究机构

第 12 章。按地区分類的脐带血库市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章脐带血库市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国脐带血库市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Cord Blood Registry, LLC
    • Cryo-Cell International, Inc.
    • ViaCord, LLC
    • StemCyte, Inc.
    • Macopharma SA
    • Stemlife Berhad
    • Cell Care Pty Ltd
    • LifeCell International Private Limited
    • Smart Cells International
    • ViaCord
Product Code: MRR-430D5F382283

The Umbilical Cord Blood Banking Market is projected to grow by USD 118.44 billion at a CAGR of 17.28% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 33.08 billion
Estimated Year [2025] USD 38.92 billion
Forecast Year [2032] USD 118.44 billion
CAGR (%) 17.28%

Comprehensive orientation to the evolving cord blood banking landscape highlighting clinical promise, operational imperatives, and regulatory dynamics shaping strategic decisions

The umbilical cord blood banking field stands at the intersection of clinical promise, technological innovation, and evolving regulatory expectations. Advances in cell processing and cryopreservation have catalyzed renewed interest among clinicians, researchers, and prospective parents, while expanding therapeutic applications are driving deeper conversations between industry and regulators. As a result, stakeholders now navigate a landscape that blends long-term custody of biological assets with near-term translational science.

In practice, banking models and service offerings reflect distinct value propositions. Private banks emphasize individualized storage for potential autologous or family-directed use, while public banks focus on allogeneic availability for transplantation and research. Concurrently, improvements in laboratory automation, quality control, and viability assessment have compressed operational variances, enabling higher consistency across providers. Regulatory frameworks continue to shape permissible activities and commercialization pathways, and organizations that align clinical evidence generation with robust quality systems gain differentiated credibility.

This introduction frames the core dynamics that follow: structural shifts across the ecosystem, policy pressures from trade measures, segmentation-specific drivers, and practical recommendations for leaders who must translate scientific opportunity into reliable, compliant services. Through this lens, the remainder of the document outlines the forces that will most influence strategic choices over the near to medium term.

How scientific advances, operational standardization, and evolving clinical partnerships are reshaping competitive priorities and quality expectations across the industry

The landscape of cord blood banking is undergoing transformative shifts driven by converging scientific advances, improvements in processing technologies, and changing stakeholder expectations. Breakthroughs in regenerative medicine and cell therapy have expanded the clinical rationale for preserving cord blood, prompting both established banks and new entrants to revisit service models and value communications. At the same time, automation and standardized viability testing have raised the baseline quality that caregivers and researchers now expect, shifting competition away from price toward demonstrated clinical utility.

Moreover, partnerships between banking organizations and biotechnology firms are accelerating translational pathways. These collaborations foster shared investment in protocols that support novel applications, including immunotherapies and regenerative indications. Concurrently, payers and health systems are beginning to evaluate long-term outcomes, which will influence reimbursement conversations and patient demand. Regulatory bodies are also adapting oversight frameworks to accommodate emerging cell-based therapies, creating new compliance requirements that necessitate proactive quality and documentation strategies.

Taken together, these factors are reshaping strategic priorities across the sector. Organizations that invest in evidence generation, strengthen traceability and cold chain governance, and cultivate clinical partnerships will navigate the transition more successfully, while those that delay integration of new technologies and regulatory alignment may face competitive and compliance risks.

Assessment of how 2025 trade policy adjustments and tariffs reshaped procurement, supply chain resilience, and collaborative research strategies within the sector

The introduction of trade policy measures and tariff adjustments by the United States in 2025 introduced a new set of operational and strategic pressures for organizations active in global supply chains supporting cord blood banking. Sourcing of specialized cryogenic freezers, laboratory consumables, and reagents often relies on cross-border suppliers, and tariff-driven input cost increases necessitated immediate reassessment of procurement strategies. In response, many stakeholders accelerated supplier diversification and intensified conversations about nearshoring of critical manufacturing capacity.

Beyond procurement, tariffs influenced collaborative research arrangements. Cross-border clinical collaborations and reagent sharing require clear contractual terms to manage cost volatility. Institutions adapted by revising contractual risk allocations and by establishing inventory buffers for time-sensitive reagents. Additionally, the heightened cost visibility prompted innovation in resource utilization, such as optimizing storage formats and improving volume reduction techniques to reduce consumable consumption per specimen.

From a strategic perspective, the tariff environment catalyzed stronger emphasis on supply chain transparency and resilience. Organizations that had previously underinvested in supplier qualification and contingency planning found themselves revisiting those priorities. Conversely, those that leveraged strategic procurement, long-term supplier agreements, and incremental investments in domestic capabilities minimized disruption and maintained continuity of clinical and research activities.

Deep segmentation analysis revealing distinct requirements across banking models, service offerings, clinical applications, and end-user expectations that drive strategic differentiation

When evaluating the market through the lens of banking model, a clear dichotomy emerges between providers focused on individualized custodial services and those oriented toward public availability and transplantation support. Private banks tend to invest in consumer-facing education, long-term customer retention, and value propositions tied to family-directed access, while public banks prioritize donor recruitment, matching systems, and integration with national transplant networks.

Examining offerings reveals discrete operational domains: collection processes that ensure sterile, timely retrieval at birth; processing functions that include cell separation, viability testing, and volume reduction to prepare units for cryostorage; release procedures that govern clinical dispatch for transplantation or research; and long-term storage systems that maintain sample integrity under rigorous traceability and temperature control. Innovations in any of these stages can materially affect downstream usability and cost structures.

Application-based segmentation highlights clinical and scientific priorities. Blood disorders such as anemia, leukemia, and lymphoma remain core therapeutic targets for cord blood transplantation, while immune disorders and metabolic conditions continue to drive research interest. Regenerative medicine and research applications expand the potential utility of stored units, requiring additional data on potency and longer-term outcomes to support wider adoption.

Finally, end users-including diagnostic laboratories, hospitals and clinics, and research institutes-engage with banks under different time horizons and quality expectations. Diagnostic laboratories often require validated sample processing and strict chain-of-custody documentation, whereas hospitals and clinics demand operational excellence at the point of collection and seamless clinical integration. Research institutes prioritize accessibility and standardized metadata to enable reproducible studies. Understanding these nuanced needs across segmentation axes informs tailored service design and contract structures.

Regional dynamics and regulatory nuances across the Americas, Europe-Middle East-Africa, and Asia-Pacific that determine investment priorities and strategic partnerships

Regional dynamics exert powerful influence on regulatory frameworks, payer attitudes, and the maturity of cord blood banking ecosystems. In the Americas, established private banking networks coexist with public registries, and clinical centers maintain strong transplantation experience that supports sustained demand for high-quality units. Regional regulatory bodies have incrementally updated guidance to accommodate cell therapies, and commercial players often emphasize consumer engagement and product differentiation.

In Europe, the Middle East & Africa region, regulatory harmonization efforts and national tissue directives shape operational requirements. Public banking infrastructure and national registries play a prominent role in certain countries, while cross-border cooperation supports transplantation matching. Regulatory nuance across jurisdictions requires banks to invest in multi-jurisdictional compliance programs and localized clinical partnerships to ensure access to varied patient populations.

Across the Asia-Pacific region, rapid adoption of novel therapies and investment in biotechnology infrastructure drive demand for both private and public banking services. Growth in clinical trials and translational research has created opportunities for collaborative models between banks and therapeutic developers. However, heterogeneity in regulatory maturity and varying reimbursement landscapes necessitate localized strategies that account for cultural, clinical, and policy differences. These regional distinctions inform where to prioritize investments in infrastructure, clinical outreach, and compliance capabilities.

Competitive landscape assessment showing how alliances, technological differentiation, and consolidation are redefining company strategies and value creation pathways

Competitive dynamics in the cord blood banking sector reflect a mix of legacy custodial providers, vertically integrated clinical service organizations, and nimble startups that commercialize novel processing and analytics technologies. Established custodial providers typically leverage scale in collection networks, customer relationships, and long-term storage operations, while newer entrants often focus on differentiated laboratory capabilities, proprietary viability assays, or partnerships with therapeutic developers.

Strategic alliances between banks and biotechnology companies have become increasingly prevalent as developers seek reliable, high-quality source material for clinical programs. These alliances frequently include co-investment in processing protocols, validation studies, and data sharing agreements that accelerate translational timelines. Similarly, technology vendors supplying automated processing platforms and advanced cryogenic hardware have created opportunities for banks to raise quality standards and reduce per-unit variability.

Mergers and acquisitions continue to influence the competitive landscape, with consolidation enabling scale economies in storage and compliance while also driving integration of clinical and research services. At the same time, institutional investors and healthcare systems are exploring joint ventures and captive banking solutions to secure access to qualified donor material for internal therapeutic pipelines. In aggregate, these company-level strategies reflect a market where differentiation increasingly rests on evidence generation, supply chain reliability, and the capacity to support clinical development partners.

Actionable strategic priorities for leaders focused on clinical evidence generation, operational resilience, strategic partnerships, and customer engagement to secure long-term value

Industry leaders should prioritize a balanced approach that strengthens clinical credibility while building operational resilience. First, invest in evidence generation through prospective registries and clinician partnerships to substantiate clinical utility across target indications. Align these efforts with robust quality systems and transparent documentation to ease regulatory interactions and support payer conversations.

Second, enhance supply chain resilience by diversifying vendors for critical equipment and consumables, negotiating multi-year agreements where feasible, and exploring regional manufacturing or procurement hubs to mitigate tariff-driven volatility. Simultaneously, adopt laboratory automation and standardized viability testing to reduce operational variability and improve unit usability for translational programs.

Third, pursue strategic collaborations with therapeutic developers and research institutes. Co-development agreements and material access arrangements can create new revenue streams and accelerate the clinical validation of cord blood-derived applications. Finally, strengthen customer-facing capabilities through clearer education, post-storage engagement, and digital portals that simplify long-term custody decisions and enable lifecycle monetization opportunities. Taken together, these actions will position organizations to capture clinical opportunities while managing regulatory and commercial risk.

Robust mixed-methods research framework combining expert interviews, regulatory review, and data triangulation to underpin evidence-based strategic recommendations

This research synthesizes primary stakeholder interviews, regulatory and clinical literature review, and observational analysis of operational practices to construct evidence-based conclusions. Primary engagement included structured conversations with laboratory directors, transplant clinicians, procurement specialists, and regulatory affairs professionals to capture practical challenges and evolving expectations. These interviews were complemented by careful review of guidance documents, clinical trial registries, and peer-reviewed studies that document procedural innovations and therapeutic outcomes.

Secondary research incorporated industry publications, technology vendor specifications, and publicly available policy updates to contextualize operational trends within broader trade and regulatory developments. Data triangulation ensured consistency across sources, with discrepant findings subjected to follow-up inquiries or cross-verification through alternate data channels. Quality assurance processes included expert peer review and scenario analysis to identify plausible responses to policy shifts and technological adoption curves.

Methodologically, the study emphasized qualitative depth over speculative quantitative projections. That emphasis enables readers to understand causal relationships, operational levers, and the pragmatic steps required to translate scientific promise into dependable services. Transparency in source attribution and methodological limitations accompanies all major assertions to support confident decision-making.

Conclusion summarizing how quality, strategic partnerships, and supply chain resilience determine which organizations will lead the next phase of therapeutic and clinical adoption

The convergence of scientific advances, operational standardization, and geopolitical pressures is reshaping the cord blood banking ecosystem in meaningful ways. Clinical opportunity now coexists with increased expectations for traceability, quality, and collaborative evidence generation. At the same time, supply chain disruptions and tariff dynamics have highlighted the importance of procurement agility and regional capacity building.

Organizations that align laboratory excellence with proactive regulatory engagement and strategic partnerships will secure competitive advantage. Investing in validated processing protocols, automated viability testing, and durable clinical relationships creates a foundation for long-term relevance. Conversely, those that delay integrating new technologies or fail to shore up supply chain resilience risk operational discontinuities and diminished clinical credibility.

In closing, the sector's trajectory favors actors who view cord blood banking not merely as a custodial service, but as an integral partner in translational science. By emphasizing quality, collaboration, and adaptability, leaders can unlock broader clinical applications while safeguarding the integrity of stored biological assets.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Growing adoption of advanced cryopreservation technologies to improve viability and longevity of stored cord blood stem cells
  • 5.2. Increasing integration of AI and blockchain for enhanced traceability and transparency in cord blood storage and usage
  • 5.3. Emergence of personalized medicine driving demand for HLA-typed cord blood units for targeted immunotherapies
  • 5.4. Expansion of public-private hybrid cord blood banks to increase accessibility in emerging economies
  • 5.5. Rising investments in research on ex vivo expansion of hematopoietic stem cells from cord blood for broader clinical applications
  • 5.6. Regulatory harmonization efforts shaping international standards for quality and safety in cord blood banking services
  • 5.7. Collaboration between biotech firms and cord blood banks to commercialize novel cell therapy products using neonatal stem cells
  • 5.8. Consumer-focused marketing campaigns emphasizing future therapeutic potentials of autologous cord blood storage
  • 5.9. Adoption of minimally invasive collection kits designed for home-based cord blood harvesting by expectant parents
  • 5.10. Implementation of cost-effective modular storage solutions reducing operational expenses for cord blood banks

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Umbilical Cord Blood Banking Market, by Banking Model

  • 8.1. Private
  • 8.2. Public

9. Umbilical Cord Blood Banking Market, by Offerings

  • 9.1. Collection
  • 9.2. Processing
    • 9.2.1. Cell Separation
    • 9.2.2. Viability Testing
    • 9.2.3. Volume Reduction
  • 9.3. Release
  • 9.4. Storage

10. Umbilical Cord Blood Banking Market, by Application

  • 10.1. Blood Disorders
    • 10.1.1. Anemia
    • 10.1.2. Leukemia
    • 10.1.3. Lymphoma
  • 10.2. Immune Disorders
  • 10.3. Metabolic Disorders
  • 10.4. Regenerative Medicine
  • 10.5. Research

11. Umbilical Cord Blood Banking Market, by End User

  • 11.1. Diagnostic Laboratories
  • 11.2. Hospitals And Clinics
  • 11.3. Research Institutes

12. Umbilical Cord Blood Banking Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Umbilical Cord Blood Banking Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Umbilical Cord Blood Banking Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Cord Blood Registry, LLC
    • 15.3.2. Cryo-Cell International, Inc.
    • 15.3.3. ViaCord, LLC
    • 15.3.4. StemCyte, Inc.
    • 15.3.5. Macopharma S.A.
    • 15.3.6. Stemlife Berhad
    • 15.3.7. Cell Care Pty Ltd
    • 15.3.8. LifeCell International Private Limited
    • 15.3.9. Smart Cells International
    • 15.3.10. ViaCord

LIST OF FIGURES

  • FIGURE 1. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. UMBILICAL CORD BLOOD BANKING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. UMBILICAL CORD BLOOD BANKING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. UMBILICAL CORD BLOOD BANKING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PRIVATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PRIVATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PRIVATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PRIVATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PUBLIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PUBLIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PUBLIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PUBLIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COLLECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COLLECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COLLECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COLLECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COLLECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COLLECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY CELL SEPARATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY CELL SEPARATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY CELL SEPARATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY CELL SEPARATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY CELL SEPARATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY CELL SEPARATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY VIABILITY TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY VIABILITY TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY VIABILITY TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY VIABILITY TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY VIABILITY TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY VIABILITY TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY VOLUME REDUCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY VOLUME REDUCTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY VOLUME REDUCTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY VOLUME REDUCTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY VOLUME REDUCTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY VOLUME REDUCTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY RELEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY RELEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY RELEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY RELEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY RELEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY RELEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY ANEMIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY ANEMIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY ANEMIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY ANEMIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY ANEMIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY ANEMIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LEUKEMIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LEUKEMIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LEUKEMIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LEUKEMIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LEUKEMIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LYMPHOMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LYMPHOMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LYMPHOMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LYMPHOMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LYMPHOMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY IMMUNE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY IMMUNE DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY IMMUNE DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY IMMUNE DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY IMMUNE DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY IMMUNE DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY METABOLIC DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY METABOLIC DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY METABOLIC DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY METABOLIC DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY REGENERATIVE MEDICINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY REGENERATIVE MEDICINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY REGENERATIVE MEDICINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY REGENERATIVE MEDICINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 141. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2025-2032 (USD MILLION)
  • TABLE 143. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2025-2032 (USD MILLION)
  • TABLE 145. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 147. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 149. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2025-2032 (USD MILLION)
  • TABLE 151. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2024 (USD MILLION)
  • TABLE 156. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2025-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 158. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2025-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 160. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 162. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 164. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2025-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 166. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2024 (USD MILLION)
  • TABLE 170. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2025-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 172. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2025-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 174. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 176. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 178. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2025-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 180. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2024 (USD MILLION)
  • TABLE 212. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2025-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 214. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2025-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 216. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 218. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 220. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2025-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 222. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 223. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2024 (USD MILLION)
  • TABLE 226. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2025-2032 (USD MILLION)
  • TABLE 227. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 228. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2025-2032 (USD MILLION)
  • TABLE 229. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 230. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 231. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 232. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 233. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 234. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2025-2032 (USD MILLION)
  • TABLE 235. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 236. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2024 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2025-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2025-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2025-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2024 (USD MILLION)
  • TABLE 256. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2025-2032 (USD MILLION)
  • TABLE 257. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 258. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2025-2032 (USD MILLION)
  • TABLE 259. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 260. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 261. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 262. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 263. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 264. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2025-2032 (USD MILLION)
  • TABLE 265. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 266. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 267. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 268. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 269. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2024 (USD MILLION)
  • TABLE 270. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2025-2032 (USD MILLION)
  • TABLE 271. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 272. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2025-2032 (USD MILLION)
  • TABLE 273. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 274. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 275. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 276. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 277. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 278. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2025-2032 (USD MILLION)
  • TABLE 279. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 295. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 296. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 297. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2024 (USD MILLION)
  • TABLE 298. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2025-2032 (USD MILLION)
  • TABLE 299. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 300. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2025-2032 (USD MILLION)
  • TABLE 301. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 302. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 303. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 304. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 305. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 306. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2025-2032 (USD MILLION)
  • TABLE 307. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 308. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)

TABLE